
Opinion|Videos|March 28, 2025
Looking Ahead: Future Landscape for Treating OFF Time and Dyskinesia
Author(s)Daniel E. Kremens, MD, JD
An expert discusses D1 receptor agonists that reduce negative symptoms and the increasing availability of recent and upcoming PUMP options for Parkinson disease treatment.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Current Treatment Strategies for Dravet Syndrome
2
NeurologyLive®'s Conference Coverage, Oveporexton Displays Symptom Improvement in NT1, FDA Allows BLA for AMT-130 in HD
3
Beyond Motor Symptoms: The Power of Connection in Parkinson Disease
4
FDA Allows AMT-130 Huntington Disease Data to Support Planned BLA Submission Under Accelerated Approval Pathway
5














